Rehab Tech Consultants
Dr. Cohen is a licensed physical therapist with a PhD in Health and Rehabilitation Sciences.  She has over 26 years of experience in all areas of rehabilitation including clinical practice, strategic planning, management, research, teaching, accreditation, and credentialing.

Throughout her career, Dr. Cohen has maintained a clinical practice specializing in neurorehabilitation, and seating and wheeled mobility services for individuals with complex needs. To keep current with clinical practice and keep pace with evolving technology, Dr. Cohen continues to provide direct patient care in the Seating and Mobility Clinic at MedStar National Rehabilitation Hospital.

For the past 15 years Dr. Cohen has been providing consultative second level review services for a third party payer reviewing durable medical equipment (DME) requests in 21 states. Also as a Senior Clinical Consultant for the van Halem Group, LLC, Dr. Cohen provides counsel, leadership, and clinical expertise to clients when it comes to medical necessity, benefit integrity, policy development and compliance. This combined experience has provided Dr. Cohen a rare view of clinical practice patterns, supplier issues, professional development needs, documentation concerns and policy matters.

In addition, Dr. Cohen is the Executive Director of the Clinician Task Force a national group of seating and mobility clinicians working to influence Medicare and Medicaid coding, coverage, and payment policies for complex rehabilitation technology devices. The Clinician Task Force (CTF) provides clinically relevant information about seating and wheeled mobility device assessment and decision making to policy makers to ensure appropriate access for individuals with disabilities. In 2009, Dr. Cohen was appointed to the Steering Committee for the Complex Rehabilitation Technology (CRT) Benefit Category Initiative that has worked to draft and gain sponsorship for legislation to create a new Medicare benefit category for CRT. In 2012, HR4378 was introduced and the Steering Committee continues to work towards passage and implementation.

Dr. Cohen is the past Chair and ex-officio member of the RESNA Professional Standards Board tasked with the administration and oversight of the RESNA Credentialing programs. In this capacity Dr. Cohen provided leadership and participation for modernizing the RESNA Assistive Technology Professional (ATP) certification program including job analysis survey, updating exam blueprint, item writing, passing score study and conversion to computer based testing. She also led the effort for developing, validating and implementing the RESNA advanced Seating and Mobility Specialist (SMS) certification program.  In addition to her experience with the NCCA accreditation process with the RESNA Certification program, Dr. Cohen has served as a CARF DMEPOS surveyor since 2008.

As a result of her diverse experience and unique perspective, Dr. Cohen has been appointed by Federal and State government agencies and contractors to serve on various panels and technical advisory boards tasked with recommending policy improvements for DME services. She has worked with Georgia, Florida, and Pennsylvania State Medicaid programs, the Veteran's Administration VISN 4 Region, the Georgia Traumatic Injury Advisory Board, Data and Evaluation Committee for the Brain and Spinal Injury Trust Fund Commission, the Technical Advisory Group to develop a Compendium of Home Modifications and Assistive Technology Policy and Practice Across the United States, and the Agency for Healthcare Research and Quality Technical Brief on Wheeled Mobility (Wheelchair) Service Delivery. At the request of the U.S. Senate Committee on Finance, Dr. Cohen provided written and oral testimony for a hearing on Medicare policy for power wheelchair provision known as "Operation Wheeler Dealer".

She is a RESNA Fellow recognized by the assistive technology community for her volunteerism and contributions to the field. Dr. Cohen's research interest is to promote outcomes research designed to influence clinical practice and impact public policy.